Daniel McGee, Board-certified Family Medicine Physician Semaglutide Treatment Goals for Type-2 Diabetes GLP-1s have been used to help control diabetes symptoms for years before being repackaged as weight loss aids
doi:10.1038/s41598-021-86516-4 Liu T, Zhou L, Chen Y, Lin J, Zhu H
In addition to its effects on blood sugar control, semaglutide also slows down gastric emptying, which can help reduce appetite and promote weight loss
Many find adequate results at 10 mg or 12.5 mg with fewer side effects
Abstract The SELECT trial previously reported a 20% reduction in major adverse cardiovascular events with semaglutide ( n = 8,803) versus placebo ( n = 8,801) in patients with overweight/obesity and established cardiovascular disease, without diabetes